Danish pharmaceutical firm Novo Nordisk announced on Thursday that it plans to take legal action against American telehealth company Hims & Hers for planning to mass-market an untested and unapproved copy of its weight loss drug Wegovy. Hims & Hers' version will be priced at $49, compared to the $149 Novo sells the branded pill for.
"The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety. Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property, and the integrity of the US gold-standard drug approval framework," the pharma firm said.
Novo claimed patient safety risks and prior FDA warnings as "another example of Hims & Hers' historic behaviour of duping the American public with knock-off GLP-1 products." Novo Nordisk's American-listed stock dropped by 6.11% to $44.31 per share at 11:17 am ET, while Hims & Hers' shares added 1.11% concurrently, going for $24.67 apiece.
https://breakingthenews.net/Article/Novo-Nordisk-to-sue-Hims-and-Hers-over-knockoff-drug/65616790
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.